WPRIM Management System> DCMS> Chinese Journal of Lung Cancer> 2018> 21> 5

Volume: 21 Issue: 5

1. A Case Report of Advanced Lung Adenocarcinoma Harboring KRAS Mutation 
Treated with Anlotinib. Page:428—430
2. Advances in Antiangiogenic Treatment of Advanced Non-squamous Non-small Cell Lung Cancer in 2017 ASCO and WCLC. Page:425—427
3. Research Progress of KRAS Mutation in Non-small Cell Lung Cancer. Page:419—424
4. Stereotactic Body Radiotherapy for Centrally Located Non-small Cell Lung Cancer. Page:413—418
5. Analysis of the First Diagnosis Symptom and Its Influencing Factors in 500 Patients with Lung Cancer. Page:408—412
6. Clinical Analysis of Small Cell Lung Cancer with Bone Marrow Metastases. Page:403—407
7. Characteristics of Ventricular Function in Pulmonary Hypertension Patients 
with Different Shape of Interventricular Septum:
Preliminary Study with Cardiac Magnetic Resonance Imaging. Page:397—402
8. Influence of Different Therapies on EGFR Mutants by Circulating Cell-free DNA of Lung Adenocarcinoma and Prognosis. Page:389—396
9. Correlations between Ape1/Ref-1, ICAM-1 and IL-17A Levels in Serum and Radiation Pneumonitis for Local Advanced Non-small Cell Lung Cancer Patients. Page:383—388
10. Role of PD 0332991 on the Proliferation and Apoptosis of Vascular Endothelial Cells. Page:375—382
11. Relationship between FGFR1 Gene Regulation of Circulating Tumor Cells and Clinical Features of Non-small Cell Lung Cancer. Page:365—374
12. Construction of EZH2 Knockout Animal Model by CRISPR/Cas9 Technology. Page:358—364
13. Preliminary Study on the Effect of Adipocytes on the Biological Behaviors of
Lung Adenocarcinoma A549 Cells in Tumor Microenvironment. Page:351—357